Non-optical screening platforms: the next wave in label-free screening?

Area of Science:

• Biotechnology
• Analytical Chemistry
• Drug Discovery

Background:

• Optical biosensors for compound screening emerged in the mid-1990s but faced market limitations due to low throughput and restricted applications for certain receptor classes.
• Recent advancements leverage non-optical detection modalities to address the shortcomings of established optical techniques.

Purpose of the Study:

• To highlight key advances in commercial label-free analysis platforms.
• To showcase how these platforms complement traditional optical systems.
• To demonstrate novel assay formats for analyzing previously intractable targets.

Main Methods:

• Exploitation of non-optical detection modalities including acoustic resonance, electrical impedance, microcantilevers, nanowires, and differential calorimetry.
• Development of commercially available products for post-high-throughput screening hit confirmation and mode-of-action studies.

Main Results:

• Emergence of commercial label-free analysis platforms based on diverse non-optical detection methods.
• These platforms offer solutions for previously intractable targets and novel assay formats.
• Advancements address limitations of throughput and application scope seen in older optical systems.

Conclusions:

• Non-optical label-free biosensor platforms represent a significant advancement in compound screening.
• These technologies enhance drug discovery by enabling the analysis of challenging targets and improving screening efficiency.
• The commercial availability of these platforms signifies a shift towards more versatile and powerful analytical tools.